Assessment of thrombin in the urine of glomerulonephritic patients by enzyme-linked immunosorbent assay

Annals of Clinical Biochemistry

Volumn 41, Issue 2, 2004, Pages 133-137

  Kitamoto, Yasunori ^a   Tomita, Kimio ^a   Imamura, Takahisa ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; HYDROLYSIS; MALE; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; URINE LEVEL;

ADULT; AGED; ANTIBODIES; BLOOD COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; MIDDLE AGED; THROMBIN;

GLOMERULUS;

EID: 1942502204     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456304322880023     Document Type: Article

References (26)

1. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160: 618-23
2. Nawroth PP, Stem DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-5
3. Rivers RP, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311-6
4. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68
5. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386: 502-6
6. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998; 95: 6642-6
7. Perez-Rodriquez R, Franchi A, Pouyssegur J. Growth factor requirements of Chinese hamster lung fibroblasts in serum free media: high mitogenic action of thrombin. Cell Biol Int Rep 1981; 5: 347-57
8. Bar-Shavit R, Kahn A, Fenton JW 2nd, Wilner GD. Receptor-mediated chemotactic response of a macrophage cell line (J774) to thrombin. Lab Invest 1983; 49: 702-7
9. Bogatkevich GS, Tourkina E, Silver RM, Ludwicka-Bradley A. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem 2001; 276: 45184-92
10. Maruyama N, Hirano F, Yoshikawa N, Migita K, Eguchi K, Tanaka H. Thrombin stimulates cell proliferation in human fibroblast-like synoviocytes in nuclear factor-kappaB activation and protein kinase C mediated pathway. J Rheumatol 2000; 27: 2777-85
11. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992; 326: 310-8
12. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Schena FP. Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis. Am J Kidney Dis 2000; 35: 726-38
13. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 2000; 191: 455-62
14. Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton JW 2nd, Wilner GD, et al. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul 1990; 1: 453-63 [erratum appears in Cell Regul 1990; 1: 873].
15. Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton JW 2nd, Wilner GD, et al. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul 1990; 1: 453-63 [erratum appears in Cell Regul 1990; 1: 873].
16. Hemandez-Rodriguez NA, Cambrey AD, Harrison NK, Chambers RC, Gray AJ, Southcott AM, et al. Role of thrombin in pulmonary fibrosis. Lancet 1995; 346: 1071-3
17. Kitamoto Y, Imamura T, Fukui H, Tomita K. Role of thrombin in mesangial proliferative glomerulonephritis. Kidney Int 1998; 54: 1767-8
18. Akiyama H, Ikeda K, Kondo H, McGeer PL. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett 1992; 146: 152-4
19. Tsiang M, Lentz SR, Dittman WA, Wen D, Scarpati EM, Sadler JE. Equilibrium binding of thrombin to recombinant human thrombo-modulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues. Biochemistry 1990; 29: 10602-12
20. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-7
21. Asakura S, Yoshida N, Matsuda M, Murayama H, Soe G. Preparation and characterization of monoclonal antibodies against the human thrombin-antithrombin III complex. Biochim Biophys Acta 1988; 952: 37-47
22. Fenton JW 2nd, Fasco MJ, Stackrow AB. Human thrombins. Production, evaluation, and properties of alpha-thrombin. J Biol Chem 1977; 252: 3587-98
23. Xu Y, Zacharias U, Peraldi MN, He CJ, Lu C, Sraer JD, et al. Constitutive expression and modulation of the functional thrombin receptor in the human kidney. Am J Pathol 1995; 146: 101-10
24. Lundbald RL, Kingdon HS, Mann KG. Thrombin. Methods Enzymol 1976; 45: 156-78
25. Harris RC, Ismail N. Extrarenal complications of the nephrotic syndrome. Am J Kidney Dis 1994; 23: 477-97
26. Border WA. Anticoagulants are of little value in the treatment of renal disease. Am J Kidney Dis 1984; 3: 308-12